LED Medical Diagnostics Inc. (TSXV:LMD) entered into a definitive purchase agreement to acquire Apteryx, Inc. for $8.82 million on January 20, 2017. LED Medical Diagnostics paid $6.987 million in cash and issued 3,385,840 common shares of LED Medical Diagnostics to the seller at CAD 0.80 representing $2.1 million of value. An additional $1.2 million of the purchase price will be paid in cash in tranches over 18 months. The final payment of $0.45 million will be paid in common shares of or in cash at the LED Medical Diagnostic’s option, 24 months from closing. The transaction will be financed primarily by an equity financing by way of a brokered private placement of units of LED Medical Diagnostics Inc. priced at $0.05 (CAD 0.06) per Unit, for gross proceeds of approximately $8.28 million (CAD 11 million). Bloom Burton & Co. Inc. acted as financial advisor for LED Medical Diagnostics Inc. The currency conversions are made through www.oanda.com.